NCT07217925 Neurofeedback and Well-Being Among People With Co-Occurring Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms
| NCT ID | NCT07217925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wayne State University |
| Condition | Well-Being, Psychological |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-11-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study will collect novel data evaluating the feasibility of a neurofeedback training program delivered to prospective clients with a history of clinically concerning trauma-related mental health symptoms who are on a wait list to receive obsessive compulsive disorder-specific psychotherapy at an outpatient mental health clinic. This study will evaluate the influence of neurofeedback training on participant's overall sense of well-being, and additionally, whether any enhanced well-being is subsequently associated with positive changes in symptoms of obsessive compulsive disorder, post-traumatic stress, dissociation and other trauma-related mental health symptoms, emotional regulation, etc.
Eligibility Criteria
Inclusion Criteria: 1. being a client placed on the clinic waitlist to receive exposure-response prevention for OCD symptoms at the Anxiety and OCD Treatment Center of Ann Arbor, in Ann Arbor, MI. 2. having self-reported symptoms of OCD; 3. having post-traumatic stress symptoms as indicated by a score of 3 or higher on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) screening measure; 4. being age 18+. 5. being a citizen of the United States of America - Exclusion Criteria: 1. a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or substance use disorder) or neurological or pervasive developmental disorder; 2. a documented history of epilepsy; 3. lifetime history of any head injury with loss of consciousness; 4. current exposure domestic or intimate partner violence or otherwise state that their current living conditions are unsafe; 5. current experiences of psychosis or suicidality within the last six months; 6. currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis; 7. currently pregnant 8. engagement in self-harming behaviors in the last 3 months that required medical attention; 9. lack of competence to understand or consent to the study procedures; 10. lack of fluency in written and spoken English. -
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07217925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Well-Being, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217925 currently recruiting?
Yes, NCT07217925 is actively recruiting participants. Contact the research team at hj1429@wayne.edu for enrollment information.
Where is the NCT07217925 trial being conducted?
This trial is being conducted at Detroit, United States.
Who is sponsoring the NCT07217925 clinical trial?
NCT07217925 is sponsored by Wayne State University. The trial plans to enroll 20 participants.